Observational studyBone marrow transplantation2019

Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study.

Guido Ghilardi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.